CompletedNot Applicable

Intravenous Administration of Magnesium Sulfate in Hysterectomy Cases

Turkey (Türkiye)48 participantsStarted 2023-11-15

Plain-language summary

In our study, it was aimed to show the contribution of intraoperative intravenous magnesium sulfate administration to peroperative opioid consumption and postoperative analgesia.

Who can participate

Age range20 Years – 70 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient undergoing abdominal hysterectomy * Between the ages of 20-70, * ASA I- II Exclusion Criteria: * Presence of hepatic and renal dysfunction, * Presence of cardiac arrhythmia or other cardiac comorbidity, * Neurological and psychiatric disorder, * Chronic use of calcium and beta blockers, * Drug or alcohol abuse, * Pregnancy and lactation status, * Patients with a history of allergy to any drug included in the study protocol

What they're measuring

The primary outcome of this study was total opioid consumption in the first 24 hours postoperatively

Timeframe: Postoperative Day 1

Trial details

NCT IDNCT05644873

SponsorOndokuz Mayıs University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-02-20

View on ClinicalTrials.gov More Abdominal Hysterectomy trials